Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch
Prenetics Global Limited - Class A Ordinary Share (PRE)
Company Research
Source: GlobeNewswire
~ October Revenue Grew 32% MoM and on Track to hit $10 Million in Monthly Revenue by December 2025 ~ CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (Nasdaq: PRE) (“Prenetics”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced a record breaking month for IM8 in October, reaching approximately $108 million in annualized recurring revenue (ARR) just 11 months after its commercial launch. Building on the momentum from last week’s successful $44 million equity offering, IM8 is positioned for accelerated global expansion and enhanced partnerships. Key highlights: IM8 delivered its strongest month to date in October with $9 million in monthly revenue, representing 32% month-over-month growth from September’s $6.8 million, driven by strong subscriber growth, elevated average order value and improved retention metrics.Demonstrating accelerating growth trajectory, IM8 achieved an all-time high single-da
Show less
Read more
Impact Snapshot
Event Time:
PRE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRE alerts
High impacting Prenetics Global Limited - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
PRE
News
- Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy) [Seeking Alpha]Seeking Alpha
- Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 MillionGlobeNewswire
- David Beckham-Backed Health Sciences Company Kills Bitcoin Treasury Plan [Yahoo! Finance]Yahoo! Finance
- Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% ParticipationGlobeNewswire
- All You Need to Know About Prenetics Global (PRE) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
PRE
Analyst Actions
- 10/29/25 - Cantor Fitzgerald
PRE
Sec Filings
- 1/6/26 - Form 6-K
- 1/5/26 - Form 6-K
- 12/30/25 - Form 6-K
- PRE's page on the SEC website